TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23907470

Group type: EXPERIMENTAL
Intervention: 0.1 % sorbate (SA)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 0.1 % benzoate (BA)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 0.2 % chlorhexidine (CHX)
Number of subjects: 20

Group type: COMPARATOR
Intervention: 0.9 % saline (NaCl)
Number of subjects: 20
Study: 18240868

Group type: EXPERIMENTAL
Intervention: PEG‐IFN‐α2b and lamivudine
Number of subjects: 0

Group type: COMPARATOR
Intervention: PEG‐IFN‐α2b monotherapy
Number of subjects: 0
Study: 15110370

Group type: EXPERIMENTAL
Intervention: Fentanyl (0.7 microg/kg bolus in 2-mL balanced salt solution)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control (2-mL balanced salt solution without analgesic)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Fentanyl group
Number of subjects: 70
Study: 11220058

Group type: EXPERIMENTAL
Intervention: Perimenstrual Symptom Management Program
Number of subjects: 0
Study: 9093341

Group type: EXPERIMENTAL
Intervention: Flow triggering (1 and 5 l/min) during pressure support ventilation (PSV) and assisted controlled mode (A/C)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pressure triggering (-1 cm H2O) during pressure support ventilation (PSV) and assisted controlled mode (A/C)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Flow triggering (1 and 5 l/min) in A/C mode
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pressure triggering (-1 cm H2O)
Number of subjects: 0
Study: 10171655

Group type: EXPERIMENTAL
Intervention: Plasmapheresis for the production of platelet rich plasma (PRP), 20% of circulating plasma volume sequestered prior to heparinization, reinfused 10 minutes after heparin reversal.
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control group (CTR) with no sequestration procedure.
Number of subjects: 115
Study: 3759280

Group type: EXPERIMENTAL
Intervention: 100 mg/day atenolol
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 200 mg/day metoprolol
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 10 mg/day mepindolol
Number of subjects: 45
Study: 30695166

Group type: EXPERIMENTAL
Intervention: Online mindfulness intervention for 8 weeks via Wechat platform
Number of subjects: 123

Group type: COMPARATOR
Intervention: Routine prenatal care (Control)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Online mindfulness intervention
Number of subjects: 123
Study: 28779926

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study: 26234968

Group type: EXPERIMENTAL
Intervention: Structured walking intervention
Number of subjects: 104

Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 104
Study: 23845057

Group type: EXPERIMENTAL
Intervention: Usual assessment plus new individualized lifestyle assessment and referral
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual lifestyle assessment and referral
Number of subjects: 0
Study: 21849282

Group type: EXPERIMENTAL
Intervention: Inactivated 2009 H1N1 influenza vaccine (25 μg)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Inactivated 2009 H1N1 influenza vaccine (49 μg)
Number of subjects: 120
Study: 19543664

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 16772789

Group type: EXPERIMENTAL
Intervention: LapMentor training (n = 10)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (n = 9)
Number of subjects: 19
Study: 15611462

Group type: EXPERIMENTAL
Intervention: Mechanical bowel preparation (MBP)
Number of subjects: 1297
Study: 11321866

Group type: EXPERIMENTAL
Intervention: Doxazosin included in 'tight control' combination therapy
Number of subjects: 2
Study: 9051818

Group type: EXPERIMENTAL
Intervention: Active compression-decompression cardiopulmonary resuscitation (ACD-CPR)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Standard CPR
Number of subjects: 33
Study: 8512162

Group type: EXPERIMENTAL
Intervention: Standardized patients (simulated patients)
Number of subjects: 59
Study: 3326701

Group type: EXPERIMENTAL
Intervention: Bendrofluazide
Number of subjects: 17354

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 17354

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17354
Study: 30447506

Group type: COMPARATOR
Intervention: Intermittent theta burst stimulation (iTBS) at the left dorsolateral prefrontal cortex (LDLPFC), 1800 pulses at 80% of motor threshold.
Number of subjects: 23

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 23
Study: 27871598

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine
Number of subjects: 44

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 44
Study: 24829298

Group type: EXPERIMENTAL
Intervention: Tauramin 10% (taurine PN)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Standard PN solution without taurine (control PN)
Number of subjects: 74
Study: 22741449

Group type: EXPERIMENTAL
Intervention: Tadalafil on demand
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Tadalafil 5 mg once daily
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Tadalafil 10 mg once daily
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 61
Study: 20538738

Group type: EXPERIMENTAL
Intervention: Perindopril
Number of subjects: 8907

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8907
Study: 19256268

Group type: EXPERIMENTAL
Intervention: Surgery for Crohn's disease
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Factors related to surgery and pharmacological treatment
Number of subjects: 62
Study: 15625257

Group type: COMPARATOR
Intervention: Diclectin (DCL) administered orally (doxylamine succinate 10 mg and pyridoxine hydrochloride 10 mg) the night before surgery, the morning of surgery, and upon hospital discharge.
Number of subjects: 146

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Diclectin (DCL)
Number of subjects: 146
Study: 14658924

Group type: EXPERIMENTAL
Intervention: Ritalin LA (10-40 mg/day)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Ritalin LA
Number of subjects: 161
Study: 10816529

Group type: EXPERIMENTAL
Intervention: Wild-type EPEC strain
Number of subjects: 20

Group type: COMPARATOR
Intervention: DeltaespB mutant strain
Number of subjects: 20
Study: 8867198

Group type: EXPERIMENTAL
Intervention: Full cognitive‐behavioural treatment programme (CBT)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Minimal intervention condition (MI)
Number of subjects: 121
Study: 1638876

Group type: EXPERIMENTAL
Intervention: Risk factors for coronary heart disease
Number of subjects: 20000
Study: 6234282

Group type: EXPERIMENTAL
Intervention: Norfloxacin (400 mg 12 hourly)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Nalidixic acid/citrate (1 sachet 8 hourly)
Number of subjects: 110
Study: 31340804

Group type: EXPERIMENTAL
Intervention: CBT‐i-based group treatment (10 weekly 90-min group sessions and scheduled telephone support)
Number of subjects: 19
Study: 29414142

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT) - one standardized Behavioral Health Consultation visit followed by three ACT-based group visits and one group booster visit.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Enhanced Treatment as Usual (E-TAU) - educational pain management handouts based on standard cognitive behavioral treatment of pain.
Number of subjects: 60
Study: 26772822

Group type: EXPERIMENTAL
Intervention: Nx4 (Neurexan ®)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 24680051

Group type: EXPERIMENTAL
Intervention: TLC‐II(C) multimedia kit
Number of subjects: 153

Group type: COMPARATOR
Intervention: Healthy Habits for Life (HHL) control kit
Number of subjects: 153
Study: 22170358

Group type: EXPERIMENTAL
Intervention: Oral folic acid (400 μg) + vitamin B-12 (100 μg) supplementation
Number of subjects: 900

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 900
Study: 21058159

Group type: EXPERIMENTAL
Intervention: Communication coaching intervention
Number of subjects: 22

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 22
Study: 17944890

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle (PFM) and fitness exercises, 60 minutes per session, twice a week for 3 months
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle (PFM) and fitness exercises
Number of subjects: 70
Study: 16323317

Group type: EXPERIMENTAL
Intervention: Interferon beta‐1a (IFNbeta‐1a)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 172
Study: 11992180

Group type: EXPERIMENTAL
Intervention: Tazarotene 0.1% gel plus betamethasone dipropionate 0.05% cream (mid-high-potency steroid)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Tazarotene 0.1% gel plus mometasone furoate 0.1% ointment (high-potency steroid)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Tazarotene 0.1% gel plus diflorasone diacetate 0.05% ointment (high-potency steroid)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Tazarotene 0.1% gel alone
Number of subjects: 200
Study: 9646148

Group type: EXPERIMENTAL
Intervention: Religious attendance (once per week or more)
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: Daily prayer or Bible study
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: Intrinsic religious attitudes
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: Religious faith as a coping factor
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: Religious attendance
Number of subjects: 455
Study: 8005121

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 25 mg plus Amiloride 2.5 mg (H+Am)
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Nifedipine slow release 20 mg (N)
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg (At)
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Atenolol 25 mg plus Chlorthalidone 6.25 mg (At+C)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 308
Study: 2511239

Group type: EXPERIMENTAL
Intervention: TRH iv administration
Number of subjects: 19

Group type: COMPARATOR
Intervention: Saline injection
Number of subjects: 19
Study: 1094965

Group type: EXPERIMENTAL
Intervention: Feprazone 600 mg daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Aspirin 3.6 g daily
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Feprazone (in uncontrolled study)
Number of subjects: 20
Study: 31307665

Group type: EXPERIMENTAL
Intervention: CCRT + RS
Number of subjects: 275

Group type: COMPARATOR
Intervention: RT + RS
Number of subjects: 275
Study: 28034518

Group type: EXPERIMENTAL
Intervention: Bioequivalence studies with both male and female subjects
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cmax or AUC
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Residual variability between sexes
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Bioequivalence conclusions
Number of subjects: 12
Study: 25572618

Group type: EXPERIMENTAL
Intervention: Online theory of planned behaviour (TPB)-based intervention
Number of subjects: 534

Group type: COMPARATOR
Intervention: Information only group (control)
Number of subjects: 534
Study: 23333201

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate 30 mg/kg (Group I)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate 40 mg/kg (Group II)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate 50 mg/kg (Group III)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Lidocaine 1.5 mg/kg (Group IV)
Number of subjects: 80
Study: 21666065

Group type: EXPERIMENTAL
Intervention: Fruits and vegetables diet (F&V)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Basal diet (control)
Number of subjects: 66
Study: 19845237

Group type: EXPERIMENTAL
Intervention: Urgotul SSD
Number of subjects: 68

Group type: COMPARATOR
Intervention: 1% silver sulfadiazine
Number of subjects: 68
Study: 16551910

Group type: EXPERIMENTAL
Intervention: Granisetron (1 mg)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Dolasetron (12.5 mg)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Dolasetron (12.5 mg) in carriers of the duplication of the CYP2D6 allele
Number of subjects: 150
Study: 15142871

Group type: EXPERIMENTAL
Intervention: Talc pleurodesis (mixed talc, mean particle size < 15 microm)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Talc pleurodesis (mixed talc)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Mixed talc
Number of subjects: 68

Group type: COMPARATOR
Intervention: Graded talc
Number of subjects: 68
Study: 11009242

Group type: EXPERIMENTAL
Intervention: Ondansetron (4 mg)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 80
Study: 8883233

Group type: EXPERIMENTAL
Intervention: FEC chemotherapy (cyclophosphamide, epirubicin, 5-fluorouracil)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Ondansetron alone
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 107
Study: 1395119

Group type: EXPERIMENTAL
Intervention: Perindopril (4 mg)
Number of subjects: 503

Group type: COMPARATOR
Intervention: Atenolol (50 mg)
Number of subjects: 503

Group type: COMPARATOR
Intervention: Captopril (25 mg b.d.)
Number of subjects: 503

Group type: COMPARATOR
Intervention: Diuretic (hydrochlorothiazide 50 mg and amiloride 5 mg)
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: Perindopril with diuretic
Number of subjects: 503

Group type: COMPARATOR
Intervention: Captopril with diuretic
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: Long-term treatment with perindopril
Number of subjects: 503
Study: 3903063

Group type: EXPERIMENTAL
Intervention: MOPP chemotherapy and supradiaphragmatic radiotherapy (40 Gy) for clinical stages IA and II2A
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: MOPP or CVPP chemotherapy followed by laparotomy and radiotherapy for clinical stages II3+A and IIB
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: No mediastinal radiotherapy for patients without mediastinal involvement
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Male patients studied
Number of subjects: 72
Study: 3301699

Group type: EXPERIMENTAL
Intervention: Oral polybacterial vaccine containing 1.5 X 10(9) killed Haemophilus influenzae per tablet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Three-monthly courses of oral polybacterial vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased immunizing dose (60 fold) without non H. influenzae bacterial species
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 0
Study: 29855331

Group type: EXPERIMENTAL
Intervention: Wolbachia-infected Ae. aegypti mosquitoes
Number of subjects: 24

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 24
Study: 29138181

Group type: EXPERIMENTAL
Intervention: GIKI2 group (GIK with intensive insulin therapy for 24 hours)
Number of subjects: 772

Group type: EXPERIMENTAL
Intervention: GIK group (GIK with nonintensive insulin therapy)
Number of subjects: 772

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 772

Group type: EXPERIMENTAL
Intervention: GIKI2 group (GIK with intensive insulin therapy)
Number of subjects: 772
Study: 26303048

Group type: EXPERIMENTAL
Intervention: Mosapride
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 24066604

Group type: EXPERIMENTAL
Intervention: Guizhi Fuling capsule high dose
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Guizhi Fuling capsule low dose
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo control group
Number of subjects: 240
Study: 21397805

Group type: EXPERIMENTAL
Intervention: Topical proparacaine anesthetic 0.5%
Number of subjects: 34

Group type: COMPARATOR
Intervention: Artificial tear solution
Number of subjects: 34
Study: 18512513

Group type: EXPERIMENTAL
Intervention: Nonbonding group in the lesion area (NBL)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Nonbonding group in sound enamel (NBS)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Bonding group in the lesion area (BL)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Bonding group in sound enamel (BS)
Number of subjects: 26
Study: 16567814

Group type: EXPERIMENTAL
Intervention: Fiber-enriched bread (31.2 g insoluble fiber/day)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control (white bread)
Number of subjects: 17
Study: 14530667

Group type: EXPERIMENTAL
Intervention: Seprafilm adhesion barrier
Number of subjects: 1791

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 1791
Study: 11029326

Group type: EXPERIMENTAL
Intervention: Surfactant (Survanta, 100 mg/kg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Air placebo
Number of subjects: 19
Study: 8826172

Group type: EXPERIMENTAL
Intervention: USP-modified lanolin
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Warm water compresses
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Expressed breast milk with air drying
Number of subjects: 177

Group type: COMPARATOR
Intervention: Control group (education about breastfeeding technique)
Number of subjects: 177
Study: 1443354

Group type: EXPERIMENTAL
Intervention: Single preoperative dose of cefotaxime (Schedule A)
Number of subjects: 3670

Group type: COMPARATOR
Intervention: One preoperative dose followed by two postoperative doses of cefotaxime (Schedule B)
Number of subjects: 3670
Study: 3914879

Group type: EXPERIMENTAL
Intervention: Intravenous pindolol for 24 hours and orally for 48 hours
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 29862871

Group type: EXPERIMENTAL
Intervention: Combined salicylic acid 20% and azelaic acid 20%
Number of subjects: 34

Group type: COMPARATOR
Intervention: Trichloroacetic acid 25%
Number of subjects: 34
Study: 29753857

Group type: EXPERIMENTAL
Intervention: 3-month retraining interval
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 6-month retraining interval
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 12-month retraining interval
Number of subjects: 96

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 96
Study: 27189973

Group type: EXPERIMENTAL
Intervention: BMS-932481 (γ-secretase modulator)
Number of subjects: 0
Study: 25229738

Group type: EXPERIMENTAL
Intervention: 0.1 Hz PAS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1 Hz PAS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5 Hz burst PAS
Number of subjects: 0
Study: 22179955

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metformin treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Any treatment
Number of subjects: 0
Study: 20030744

Group type: EXPERIMENTAL
Intervention: Muscle Pain Detection Device (MPDD)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Manual Pressure (MP)
Number of subjects: 40
Study: 18669425

Group type: EXPERIMENTAL
Intervention: Cellulose sulfate gel
Number of subjects: 1398

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1398
Study: 16087822

Group type: EXPERIMENTAL
Intervention: Risedronate sodium 2.5 mg daily
Number of subjects: 280

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 280
Study: 12169971

Group type: EXPERIMENTAL
Intervention: Dynamic Observing Tonometer
Number of subjects: 40
Study: 9792935

Group type: EXPERIMENTAL
Intervention: Epoetin alfa (300 IU/kg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Epoetin alfa (150 IU/kg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Epoetin alfa (75 IU/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 7649702

Group type: EXPERIMENTAL
Intervention: Bicycle ergometer
Number of subjects: 9

Group type: COMPARATOR
Intervention: Treadmill
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Constant load exercise test
Number of subjects: 9
Study: 2614521

Group type: EXPERIMENTAL
Intervention: 4% lidocaine cream mixed with 500 mg acid mantle cream
Number of subjects: 44

Group type: COMPARATOR
Intervention: 500 mg acid mantle cream
Number of subjects: 44
Study: 641913

Group type: EXPERIMENTAL
Intervention: Combined azathioprine and prednisone therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prednisone alone
Number of subjects: 0
Study: 31635933

Group type: EXPERIMENTAL
Intervention: Individually sequenced specimens
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pooled specimens (pool sizes of 10, 20, and 40)
Number of subjects: 0
Study: 28369332

Group type: EXPERIMENTAL
Intervention: Orsiro DES
Number of subjects: 124

Group type: COMPARATOR
Intervention: Nobori DES
Number of subjects: 124
Study: 26848888

Group type: EXPERIMENTAL
Intervention: Multicomponent fitness training (1 hour, twice per week for 1 year)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no physical training)
Number of subjects: 26
Study: 24945241

Group type: EXPERIMENTAL
Intervention: Intensive exercise group
Number of subjects: 75

Group type: COMPARATOR
Intervention: Regular exercise group
Number of subjects: 75
Study: 22516665

Group type: EXPERIMENTAL
Intervention: Computer-based simulator (GI-Mentor, Symbionix) before hands-on training
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Computer-based simulator (GI-Mentor, Symbionix) during hands-on training
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (15 experts)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hands-on training
Number of subjects: 12
Study: 20435263

Group type: EXPERIMENTAL
Intervention: Open surgical bypass
Number of subjects: 100

Group type: COMPARATOR
Intervention: Endovascular therapy (angioplasty)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Prosthetic bypass grafts
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Surgical bypass after failed angioplasty
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Health-related quality of life measures and costs
Number of subjects: 100
Study: 17997890

Group type: EXPERIMENTAL
Intervention: CIK cells treatment
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group treatment (VitB4, batilol, leucogen, inosine, stanozolol)
Number of subjects: 32
Study: 15844075

Group type: EXPERIMENTAL
Intervention: 9-valent pneumococcal conjugate vaccine (PnCV)
Number of subjects: 39836